Aqualung Therapeutics leadership are experienced academic leaders, entrepreneurs and translational scientists with expertise in Precision Medicine, who have driven NAMPT as a druggable target and novel diagnostic in acute and chronic lung inflammatory disorders.
Joe "Skip" G.N. Garcia, MD
Founder and Chief Executive Officer
University of Arizona Endowed Merlin K. DuVal MD Professor of Medicine and an elected member of the National Academy of Medicine. Dr. Garcia is a internationally recognized physican-scientist with over 30 years of research experience in pulmonary disease. For more information, click here.
STAN MIELE, BA
Chief OPERATING Officer
A recognized global executive with success in sales, marketing and P&L leadership in the pharmaceutical/medical device and biotech industries, Mr. Miele was formally the Chief Commercial Officer at bioLytical Laboratories and Sucampo Pharmaceuticals Inc. He will assist with Aqualung Therapeutics global alliances and company strategies toward commercialization.
Eddie T. Chiang, MA
Chief BUSINESS Officer
Over 15 years of business and high-level academic health sciences research and administrative experience.
Sara M. Camp, BA
Chief Research Officer
Specializes in the genomic and proteomic studies of lung injury with over 15 years experience with the Garcia research group.
THE SCIENTIFIC ADVISORY BOARD
Bill Macias, MD PhD
Robert Strieter, MD